A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)
Clinical trial NCT07761429 · RECRUITING
Trial details
- NCT number
- NCT07761429
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-08
- Primary completion
- 2027-12-30
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.